Suchergebnisse - "Colin D. Funk"

PubPharm (12)

1

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective

in: Viruses | 2021

von Colin D. Funk | Craig Laferrière | Ali Ardakani

2

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes

in: Frontiers in Pharmacology | 2020

von Colin D. Funk | Colin D. Funk | Ali Ardakani

3

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

in: Frontiers in Pharmacology | 2020

von Colin D. Funk | Craig Laferrière | Ali Ardakani

4

Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice1,2[S]

in: Journal of Lipid Research | 2018

von Xinzhi Li | Liudmila L. Mazaleuskaya | Laurel L. Ballantyne | +3

5

Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions1,2[S]

in: Journal of Lipid Research | 2018

von Xinzhi Li | Liudmila L. Mazaleuskaya | Chong Yuan | +5

6

Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice

in: Molecular Therapy: Nucleic Acids | 2018

von Yuan Yan Sin | Laurel L. Ballantyne | Christopher R. Richmond | +1

7

Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice.

in: PLoS ONE | 2017

von Richard Yang Cao | Robert Eves | Lilly Jia | +3

8

Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency

in: Scientific Reports | 2017

von Yuan Yan Sin | Phillipe R. Price | Laurel L. Ballantyne | +1

9

Strategies to rescue the consequences of inducible arginase-1 deficiency in mice.

in: PLoS ONE | 2015

von Laurel L Ballantyne | Yuan Yan Sin | Tim St Amand | +7

10

Ex Vivo Akt/HO-1 Gene Therapy to Human Endothelial Progenitor Cells Enhances Myocardial Infarction Recovery

in: Cell Transplantation | 2012

von Keith R. Brunt | Jun Wu | Zhilin Chen | +6